SEM icon

Select Medical

17.68 USD
-1.38
7.24%
At close Feb 21, 4:00 PM EST
After hours
17.56
-0.12
0.68%
1 day
-7.24%
5 days
-5.71%
1 month
-8.54%
3 months
-54.75%
6 months
-48.15%
Year to date
-5.91%
1 year
-33.78%
5 years
-37.33%
10 years
35.90%
 

About: Select Medical Holdings Corp is a healthcare company that operates through four main segments: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and Concentra institutions. Critical illness recovery hospitals and rehabilitation centres are designed for patients requiring extended recovery time with medical services. These two sectors combined compose roughly half of the total revenue and include over 103 critical illness recovery hospitals and inpatient rehab facilities. The outpatient rehabilitation segment includes over 1,928 rehabilitation clinics. The Concentra segment includes over 540 occupational health centers and 147 onsite clinics. The company is headquartered in Pennsylvania, and it operates across the United States.

Employees: 54,600

0
Funds holding %
of 7,139 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

1,233% more call options, than puts

Call options by funds: $200K | Put options by funds: $15K

71% more repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 68

5.66% more ownership

Funds ownership: 75.63% [Q3] → 81.29% (+5.66%) [Q4]

7% less funds holding

Funds holding: 283 [Q3] → 262 (-21) [Q4]

25% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 60

42% less capital invested

Capital invested by funds: $3.43B [Q3] → $1.99B (-$1.44B) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$21
19%
upside
Avg. target
$21
19%
upside
High target
$21
19%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
UBS
A.J. Rice
31% 1-year accuracy
5 / 16 met price target
19%upside
$21
Neutral
Maintained
3 Jan 2025

Financial journalist opinion

Based on 4 articles about SEM published over the past 30 days

Neutral
Seeking Alpha
20 hours ago
Select Medical Holdings Corporation (SEM) Q4 2024 Earnings Call Transcript
Select Medical Holdings Corporation (NYSE:SEM ) Q4 2024 Earnings Conference Call February 21, 2025 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Senior Executive Vice President of Strategic Finance and Operations Michael Malatesta - Executive Vice President and CFO Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendricks - RBC Capital Markets Joanna Gajuk - Bank of America Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Fourth Quarter and Full Year 2024 Results and the Company's Business Outlook. Speaking today are the Company's Executive Chairman and Co-Founder, Robert Ortenzio; the Company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson; and Executive Vice President and CFO, Michael Malatesta.
Select Medical Holdings Corporation (SEM) Q4 2024 Earnings Call Transcript
Negative
Zacks Investment Research
1 day ago
Select Medical (SEM) Lags Q4 Earnings Estimates
Select Medical (SEM) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.36 per share a year ago.
Select Medical (SEM) Lags Q4 Earnings Estimates
Neutral
PRNewsWire
1 day ago
Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2024, Its 2025 Business Outlook, and Cash Dividend
MECHANICSBURG, Pa. , Feb. 20, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2024, its 2025 business outlook, and the declaration of a cash dividend.
Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2024, Its 2025 Business Outlook, and Cash Dividend
Neutral
PRNewsWire
4 weeks ago
Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2024 Results on Thursday, February 20, 2025
MECHANICSBURG, Pa. , Jan. 23, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and year ended December 31, 2024 on Thursday, February 20, 2025 after the market closes.
Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2024 Results on Thursday, February 20, 2025
Neutral
Zacks Investment Research
1 month ago
SEM Plunges 48.2% in 6 Months: Should You Buy, Hold or Sell the Stock?
Rising expenses and high leverage are impacting Select Medical's prospects.
SEM Plunges 48.2% in 6 Months: Should You Buy, Hold or Sell the Stock?
Neutral
PRNewsWire
2 months ago
Select Medical Holdings Corporation Closes Offering of $550 Million of 6.250% Senior Notes due 2032 by Select Medical Corporation
MECHANICSBURG, Pa. , Dec. 3, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation, a wholly-owned subsidiary of Holdings ("Select"), has completed a private offering (the "Offering") of $550.0 million in aggregate principal amount of its 6.250% senior notes due 2032 (the "notes").
Select Medical Holdings Corporation Closes Offering of $550 Million of 6.250% Senior Notes due 2032 by Select Medical Corporation
Positive
Zacks Investment Research
2 months ago
5 Low Price-to-Book Value Stocks to Buy in December
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, SEM, AXS, ZIM and PFE are some such stocks.
5 Low Price-to-Book Value Stocks to Buy in December
Positive
Zacks Investment Research
2 months ago
All You Need to Know About Select Medical (SEM) Rating Upgrade to Buy
Select Medical (SEM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About Select Medical (SEM) Rating Upgrade to Buy
Negative
Zacks Investment Research
2 months ago
After Plunging -38.05% in 4 Weeks, Here's Why the Trend Might Reverse for Select Medical (SEM)
The heavy selling pressure might have exhausted for Select Medical (SEM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
After Plunging -38.05% in 4 Weeks, Here's Why the Trend Might Reverse for Select Medical (SEM)
Neutral
Zacks Investment Research
2 months ago
Select Medical Distributes Concentra Shares to Shareholders
By separating from Concentra, which specializes in occupational health services, SEM can better allocate resources to its primary segments.
Select Medical Distributes Concentra Shares to Shareholders
Charts implemented using Lightweight Charts™